MedPath

Impact of Body Schema Distortion on Remission and Weight Regain in Anorexia Nervosa

Not Applicable
Recruiting
Conditions
Anorexia Nervosa
Interventions
Other: PAQ questionnaire
Other: F-DFlex questionnaire
Other: BSQ questionnaire
Other: Silhouette testing
Other: Eating Disorder Inventory - 2
Other: EDEQ questionnaire
Other: STAI questionnaire
Other: BECK questionnaire
Registration Number
NCT05682417
Lead Sponsor
Hospices Civils de Lyon
Brief Summary

Anorexia nervosa is a predominantly female eating disorder that most often appears in adolescence. The latter leads to strict and voluntary food deprivation for several months or even years. The lifetime prevalence of anorexia is 1.4% in women and 0.2% in men.

Ultimately, only half of people treated for anorexia nervosa in adolescence recover, 30% simply improve, 21% suffer from chronic disorders and 5 to 6% die. At the same time, between a quarter and half of patients abandon their current treatment, including during hospitalization. Relapses occur during the evolution of anorexia nervosa. Even more worrying, mortality is highest the year following the patient's discharge from hospital. This appears to be due to somatic complications in more than half of cases (most often cardiac arrest), to suicide in 27% of cases.

Researchers are still trying to clarify the mechanisms involved in the emergence and persistence of this disorder. The objective is to obtain more verified and faster cures. However, the obstacles to successful treatment are mainly due to the denial of disorders and thinness.

From a neurocognitive perspective, the representation one has of one's body is underpinned by two types of representations, i.e. body image and body schema.

It has long been shown that body image is altered in anorexia nervosa. More recently, authors have shown that the distortion of the body representation was however more extensive and also affected the body schema. Patients find themselves too fat despite obvious thinness and move through space as if this were really the case.

Worryingly, these distortions in bodyschema seem to persist after therapeutic management. Despite the potential role of body-scheme distortions in maintaining the disorder, as well as the risk of relapse, the difficulties in assessing body-scheme are significant. Indeed, recovery in these pathologies is often determined according to the Body Mass Index, self-declaration and questionnaires evaluating body image, again limiting the verification of the resorption of distortions in the body schema.

Investigators have therefore developed the systematic, ergonomic and simplified evaluation of the body schema in patients suffering from anorexia nervosa at the time of diagnosis in an expert center, but also during follow-up evaluations thanks to the use of an evaluation platform of the body schema, i.e. the body in brain platform, developed by the LIP/PC2S laboratory and the SATT Linksium which allows the evaluation of the body schema.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
Female
Target Recruitment
42
Inclusion Criteria
  • Patient over 15 years old
  • Women
  • Patient with a BMI <18.5
  • Patient suffering from anorexia nervosa (DSM V, 2013)
  • Patient agreeing to participate in the study with signed informed consent (Or whose parents/holder of parental authority have signed the informed consent)
  • Patient affiliated to a Social Security plan or beneficiary of such a plan
Exclusion Criteria
  • Adult patients protected by a legal protection measure (guardianship, curatorship, etc.)
  • Patients participating in another research that may interfere with this research
  • Patients with acute and co-occurring psychiatric comorbidities (suicidal crisis, delusions)
  • Patients not fluent in French
  • Pregnant, parturient or breastfeeding women (on questioning of the patient)
  • Persons deprived of their liberty by a judicial or administrative decision
  • Persons admitted to a health or social establishment for purposes other than research
  • Patients with any current pathology or history of psychotic disorders, migraine, epilepsy, balance disorders, vertigo, visual disorders, proprioceptive disorders and/or neuromuscular disorders.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Patients with anorexia nervosa according to DSM-5BSQ questionnairePatients over 15 years old, suffering from anorexia nervosa according to DSM-V with a BMI\<18.5 and without psychiatric comorbidities
Patients with anorexia nervosa according to DSM-5PAQ questionnairePatients over 15 years old, suffering from anorexia nervosa according to DSM-V with a BMI\<18.5 and without psychiatric comorbidities
Patients with anorexia nervosa according to DSM-5F-DFlex questionnairePatients over 15 years old, suffering from anorexia nervosa according to DSM-V with a BMI\<18.5 and without psychiatric comorbidities
Patients with anorexia nervosa according to DSM-5Silhouette testingPatients over 15 years old, suffering from anorexia nervosa according to DSM-V with a BMI\<18.5 and without psychiatric comorbidities
Patients with anorexia nervosa according to DSM-5EDEQ questionnairePatients over 15 years old, suffering from anorexia nervosa according to DSM-V with a BMI\<18.5 and without psychiatric comorbidities
Patients with anorexia nervosa according to DSM-5STAI questionnairePatients over 15 years old, suffering from anorexia nervosa according to DSM-V with a BMI\<18.5 and without psychiatric comorbidities
Patients with anorexia nervosa according to DSM-5BECK questionnairePatients over 15 years old, suffering from anorexia nervosa according to DSM-V with a BMI\<18.5 and without psychiatric comorbidities
Patients with anorexia nervosa according to DSM-5Eating Disorder Inventory - 2Patients over 15 years old, suffering from anorexia nervosa according to DSM-V with a BMI\<18.5 and without psychiatric comorbidities
Primary Outcome Measures
NameTimeMethod
Overestimation of the body schemaBaseline (T0); 6 months after baseline (T+6); 12 months after baseline (T+12)

Overestimation of the body schema (in percentage) assessed by the body schema assessment platform (MOVE tool, motion assessment in virtual reality).

Overestimation of the body schema (percentage of distortion) will be compared to normal values, and then compared with the percentages at T+6 and T+12.

Secondary Outcome Measures
NameTimeMethod
Cognitive rigidity scoreBaseline T0; 6 months; 12 months

The cognitive rigidity score is measured with the D-Flex questionnaire comprising 20 questions. The patient must then respond to the proposed statements using a 6-point scale (Strongly disagree (1), Somewhat disagree (2), Somewhat disagree (3), Somewhat agree (4) , Somewhat agree (5, Strongly agree (6).

Body dissatisfaction scoreBaseline T0; 6 months; 12 months

Body dissatisfaction is measured with the BSQ questionnaire comprising 34 questions rated from 1 (never) to 6 (Always)

Weight/height ratio, expressed by body mass index (BMI)Baseline T0; 6 months; 12 months

This weight(kg)/height(m)2 ratio is measured using a mathematical formula. It will be analyzed using the DSM-V reference table to measure the severity of the disorder.

Lightweight: BMI \> or = 17 kg/m2 Moderate: BMI 16-16.99 kg/m2 Severe: BMI: 15-15.99 kg/m2 Extreme: BMI \< 17 kg/m2

Body overstatementBaseline T0; 6 months; 12 months

Body overestimation is assessed using the computerized silhouette test. This test presents 27 figures with BMIs ranging from 11 to 40. The patient answers whether or not the figure presented corresponds to his current figure.

Alexithymia scoreBaseline T0; 6 months; 12 months

Alexithymia is assessed with the PAQ questionnaire consisting of 24 questions with 7 degrees of response. (1 strongly disagree - 2 - 3 - 4 Neither agree nor disagree -5 - 6 - 7 strongly agree)

Eating behavior assessed by the EDI-2 questionnaireBaseline T0; 6 months; 12 months

The eating behavior will be assessed by the EDI-2 questionnaire

Eating behavior assessed by the EDE-Q questionnaireBaseline T0; 6 months; 12 months

The eating behavior will be assessed by the EDE-Q

Level of anxietyBaseline T0; 6 months; 12 months

Anxiety is measured by STAI questionnaire.

Level of DepressionBaseline T0; 6 months; 12 months

Depression is measured by BECK questionnaire

Trial Locations

Locations (1)

Referral Center for Eating Disorders. Neurological Hospital-GH East / Hôpital Neurologique Pierre Wertheimer GHE HCL

🇫🇷

Bron, France

© Copyright 2025. All Rights Reserved by MedPath